Vivos Therapeutics, Inc.

The momentum for this stock is not very good. Vivos Therapeutics, Inc. is not a good value stock. Vivos Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Vivos Therapeutics, Inc..
Log in to see more information.

News

Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story
Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story

Simply Wall St Vivos Therapeutics, Inc. ( NASDAQ:VVOS ) shareholders would be excited to see that the share price has had a great...\n more…

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update

Ticker Report Vivos Therapeutics, Inc. (NASDAQ:VVOS - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling...\n more…

Vivos Therapeutics (NASDAQ:VVOS) Price Target Increased to $6.60 by Analysts at Ascendiant Capital Markets
Vivos Therapeutics (NASDAQ:VVOS) Price Target Increased to $6.60 by Analysts at Ascendiant Capital Markets

Zolmax Vivos Therapeutics (NASDAQ:VVOS - Free Report) had its price target hoisted by Ascendiant Capital Markets from $6.40 to $6.60 in a report published on Tuesday morning, Benzinga reports. They...\n more…

Vivos Therapeutics (NASDAQ:VVOS) Trading 3.6% Higher
Vivos Therapeutics (NASDAQ:VVOS) Trading 3.6% Higher

Ticker Report Vivos Therapeutics, Inc. (NASDAQ:VVOS - Get Free Report) shares shot up 3.6% during mid-day trading on Friday . The stock traded as high as $2.44 and last traded at $2.33. 22,605 shares changed hands...\n more…

Vivos Therapeutics (NASDAQ:VVOS) Shares Up 3.6%
Vivos Therapeutics (NASDAQ:VVOS) Shares Up 3.6%

Zolmax Vivos Therapeutics, Inc. (NASDAQ:VVOS - Get Free Report) shares traded up 3.6% during mid-day trading on Friday . The company traded as high as $2.44 and last traded at $2.33. 22,605 shares were...\n more…

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript...\n more…